Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

LONDON--()-- 

Ap19

FORM 8.3 - Amendment to Purchases & Sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 16 July 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)

(1)

Relevant securities

1,892,713

1.47%

240,773

0.19%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

1,359

0.00%

158,150

0.12%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,900,172

1.47%

405,023

0.31%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit

Purchase

13

222.1492 USD

Purchase

20

221.4400 USD

Purchase

45

221.8700 USD

Purchase

76

222.2400 USD

Purchase

92

222.1300 USD

Purchase

99

221.8900 USD

Purchase

100

223.1383 USD

Purchase

100

222.0500 USD

Purchase

230

221.7332 USD

Purchase

264

222.1637 USD

Purchase

272

221.5638 USD

Purchase

280

222.2900 USD

Purchase

349

221.8907 USD

Purchase

762

222.3245 USD

Purchase

953

222.3394 USD

Purchase

960

221.6355 USD

Purchase

1,245

221.9662 USD

Purchase

1,333

222.4935 USD

Purchase

1,680

221.8260 USD

Purchase

1,766

222.8248 USD

Purchase

1,857

221.8395 USD

Purchase

2,206

222.3018 USD

Purchase

2,751

222.6754 USD

Purchase

2,972

222.3600 USD

Purchase

3,208

221.9241 USD

Purchase

3,208

222.6663 USD

Purchase

3,851

222.4435 USD

Purchase

5,283

222.4936 USD

Purchase

6,000

220.0000 USD

Sale

5

222.2800 USD

Sale

6

221.9700 USD

Sale

22

223.3100 USD

Sale

22

221.8272 USD

Sale

100

222.0200 USD

Sale

100

221.7800 USD

Sale

100

222.9200 USD

Sale

120

221.7840 USD

Sale

186

222.7713 USD

Sale

320

222.0962 USD

Sale

380

222.2900 USD

Sale

618

222.3664 USD

Sale

953

222.3394 USD

Sale

961

222.3600 USD

Sale

1,026

222.2831 USD

Sale

1,796

222.4245 USD

Sale

1,915

222.3497 USD

Sale

2,200

222.4789 USD

Sale

2,206

222.3018 USD

Sale

2,451

222.7410 USD

Sale

4,609

222.6126 USD

Sale

5,881

222.6165 USD

Sale

10,000

221.8551 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

20 Jul 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 741891
Time of Receipt (offset from UTC): 20210720T132653+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC